本次上市,轩竹生物拟定的发售价为每股11.60港元,募资总额约为7.81亿港元,募资净额约为7.01亿港元。其中,北京德诺瑞朗十五期股权投资基金中心(有限合伙)(德诺瑞朗十五期)为基石投资者,出资约7660万港元认购。近日,轩竹生物科技股份有限公司-B(下称“轩竹生物”,HK:02575)披露发售公告,于10月6日至10月10日招股,拟全球发售6733.35万股,预计将于2025年10月15日在...
Source Link本次上市,轩竹生物拟定的发售价为每股11.60港元,募资总额约为7.81亿港元,募资净额约为7.01亿港元。其中,北京德诺瑞朗十五期股权投资基金中心(有限合伙)(德诺瑞朗十五期)为基石投资者,出资约7660万港元认购。近日,轩竹生物科技股份有限公司-B(下称“轩竹生物”,HK:02575)披露发售公告,于10月6日至10月10日招股,拟全球发售6733.35万股,预计将于2025年10月15日在...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.